Insulin
Assets acting on this target.
- Class
- Insulin
- Notes
- openFDA EPC fill 2026-08-24 (exact-name label match: Insulin human); source: https://api.fda.gov/drug/label.json?search=openfda.generic_name%3A%22Insulin+human%22+openfda.brand_name%3A%22Insulin+human%22&limit=12
By indication
Related mechanisms
Insulin drugs compared
3 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| Afrezza | Cipla, MannKind Corporation | peptide | Approved | Approved in Type 1 Diabetes; Approved in Type 2 Diabetes |
| Insulin human | Eli Lilly | Not recorded | Approved | Approved in Type 1 Diabetes |
| ORMD-0801 | Lifeward Ltd. | peptide | Phase 3 | Phase 3 in Type 2 Diabetes; Phase 2 in MASH / NASH |